Condition: Locally Recurrent Head and Neck Cancer · Sponsor: University of Erlangen-Nürnberg Medical School
The aim of the present trial is to assess the prospective results of protocol-based interstitial pulsed-dose-rate (PDR) brachytherapy with interstitial hyperthermia (iHT) in a group of selected patients where salvage surgery with clear resection margins was not possible.
This description comes directly from the study's public registry record.
Vratislav Strnad, MD · ++49 9131 85 · vratislav.strnad@uk-erlangen.de
Always discuss trial participation with your own doctor first.
| Dept. of Radiation Therapy, University Hospital Erlangen | Erlangen, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03238378